CT-388
Enith2
Roche · Phase 3 · Recruiting · Enrollment 1600
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Arm 1: Placebo | n/r | n/r | n/r | n/r | n/r |
| Arm 2: Enicepatide Dosing Regimen 1 | n/r | n/r | n/r | n/r | n/r |
| Arm 3: Enicepatide Dosing Regimen 2 | n/r | n/r | n/r | n/r | n/r |
| Arm 4: Enicepatide Dosing Regimen 3 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.